GeNeuro: Recent Study Demonstrates the Strong Link Between SARS‑CoV‑2 Infection and HERV-W Activation in Hospitalized Psychotic Patients Seite 1
11.09.2023 - Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases, such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe ... Seite 1